Hologic, Cytyc merger plans advance

Hologic Inc. of Bedford and Cytyc Corp. of Marlborough announced today the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act in connection with their proposed merger.

In May, Hologic said it had agreed to buy Cytyc for $6.2 billion in a deal that would pair two companies focused on women's health.

Hologic makes such products as devices that measure bone density for diagnosing such diseases as osteoporosis; some of Cytyc's products are used in cervical cancer screening.

The companies said today that they do not believe any further antitrust approvals are required to complete the transaction.

The transaction is subject to approval of both companies' shareholders as well as other customary closing conditions, and the transaction is expected to close in the third calendar quarter of 2007, the companies said.
(By Chris Reidy, Globe staff)